Megan Boston insider trades
Open-market stock purchases and sales by Megan Boston, Chief Financial Officer at Benitec Biopharma Inc, from SEC Form 4 filings since Dec 9, 2020.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +173%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 18, 2025 | BNTC Benitec Biopharma Inc | Bought (not open market) | — |
Companies traded
- BNTC Benitec Biopharma Inc: 1 buy, last Nov 18, 2025